June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Distinct rod and cone precursor transcriptomic responses to pRB loss reveals a metabolic predisposition to retinoblastoma initiation
Author Affiliations & Notes
  • Zachary Fouladian
    The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
    Development, Stem Cell, and Regenerative Medicine Program, University of Southern California Keck School of Medicine, Los Angeles, California, United States
  • Sunhye Lee
    The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Kevin Stachelek
    The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
    Cancer Biology and Genomics Program, University of Southern California Keck School of Medicine, Los Angeles, California, United States
  • Martin Triska
    The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Hardeep Singh
    The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
    Department of Ophthalmology and Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California, United States
  • Matthew Thornton
    Maternal-Fetal Medicine Division of the Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California, United States
  • Brendan Grubbs
    Maternal-Fetal Medicine Division of the Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California, United States
  • David Cobrinik
    The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
    Department of Ophthalmology and Roski Eye Institute; Department of Biochemistry & Molecular Medicine; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, University of Southern California Keck School of Medicine, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Zachary Fouladian None; Sunhye Lee None; Kevin Stachelek None; Martin Triska None; Hardeep Singh None; Matthew Thornton None; Brendan Grubbs None; David Cobrinik None
  • Footnotes
    Support  NIH Grant R01CA137124
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3744. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zachary Fouladian, Sunhye Lee, Kevin Stachelek, Martin Triska, Hardeep Singh, Matthew Thornton, Brendan Grubbs, David Cobrinik; Distinct rod and cone precursor transcriptomic responses to pRB loss reveals a metabolic predisposition to retinoblastoma initiation. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3744.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cone precursors (CPs) form retinoblastomas in response to RB1 loss, while rod precursors (RPs) do not. Transcriptomic features that distinguish CP versus RP responses are poorly defined. Here we examined time-dependent gene expression changes of pRB-depleted fetal CP and RPs to identify transcriptomic changes that control retinoblastoma initiation.

Methods : Human fetal retina photoreceptor precursors were FACS isolated, transduced with shRNAs targeting RB1 (shRB1) or a non-targeting control (shSCR), and subjected to SMART-Seq full-length scRNAseq at 4 - 12 days post-transduction. Principal components that segregate transcriptomes according to culture time and pRB knockdown status were identified and cell states defined by hierarchical clustering, pseudotemporal trajectory reconstruction, and differential gene expression analysis. Explanted pRB-depleted retina was treated with PGMI-004A followed by immunofluorescent analysis of Ki67, Cyclin A, and Cyclin B expression and EdU incorporation.

Results : Pseudotemporal trajectories were deduced and gene expression changes identified for pRB-depleted CPs and RPs. Among other changes, we found a 3-fold reduction of PGAM1 RNA in RPs versus a 1.2-fold reduction in CPs. As PGAM1 regulates glycolysis and nucleotide synthesis, we determined if PGAM activity is needed for CP proliferation. Compared to retinae transduced with shRB1 alone, those treated with PGAM1 inhibitor PGMI-004A had an increased percentage of Ki67+ CPs (43.7% vs 27.9%) but no EdU incorporation (0.0% vs 24.8%, p < 0.001, Fisher's exact test for both). PGMI-004A-treated pRB-depleted Ki67+ cone precursors had more frequent co-expression of S phase marker Cyclin A2 (73.7% vs 59.2%) and reduced co-expression of G2/M marker Cyclin B (20.4% vs 62.8%, p < 0.05, Fisher’s exact test for both).

Conclusions : CP and RP transcriptomic responses to RB1 loss were established. PGAM1 expression was abrogated in pRB-depleted RPs but persisted in pRB-depleted CPs. PGAM1 activity was not required for CP cell cycle entry but was needed for nucleotide incorporation and progression past S phase, These findings demonstrate that cell type-specific responses to pRB loss underlie the cone precursor’s tumorigenic potential and suggest that cone-specific regulation of metabolic proteins is critical in retinoblastoma initiation.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×